Literature DB >> 8223666

Comparison of a commercial enzyme immunoassay and an immunoblot technique for detection of immunoglobulin A antibodies to Toxoplasma gondii.

U Gross1, W Bohne, J Schröder, T Roos, J Heesemann.   

Abstract

A commercial enzyme immunoassay (Platelia-Toxo IgA) and an immunoblot technique were compared with regard to their ability to detect IgA antibodies to the major surface protein P30(SAG1) of Toxoplasma gondii in 105 serum samples from patients with suspected or proven acquired toxoplasmosis. Comparison of the IgA-EIA with the immunoblot technique showed a concordance of 81.0%, with a sensitivity of 92.6% and a specificity of 78.4%. Due to its high sensitivity the IgA-EIA might detect IgA antibodies against Toxoplasma gondii at an early stage of infection, although excessive sensitivity could lead to detection of IgA antibodies for an extended period of time following the onset of infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223666     DOI: 10.1007/bf01973647

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  IgA antibodies against P30 as markers of congenital and acute toxoplasmosis.

Authors:  A Decoster; F Darcy; A Caron; A Capron
Journal:  Lancet       Date:  1988-11-12       Impact factor: 79.321

2.  IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis.

Authors:  P Stepick-Biek; P Thulliez; F G Araujo; J S Remington
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

3.  Comparison of the indirect fluorescent antibody test and methylene blue dye test for detection of antibodies to Toxoplasma gondii.

Authors:  B C Walton; B M Benchoff; W H Brooks
Journal:  Am J Trop Med Hyg       Date:  1966-03       Impact factor: 2.345

4.  Improved sensitivity of the polymerase chain reaction for detection of Toxoplasma gondii in biological and human clinical specimens.

Authors:  U Gross; A Roggenkamp; K Janitschke; J Heesemann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-01       Impact factor: 3.267

5.  Improved serological diagnosis of Toxoplasma gondii infection by detection of immunoglobulin A (IgA) and IgM antibodies against P30 by using the immunoblot technique.

Authors:  U Gross; T Roos; D Appoldt; J Heesemann
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

6.  Toxoplasma antigens recognized by human immunoglobulin A antibodies.

Authors:  J Huskinson; P Thulliez; J S Remington
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

7.  Use of a monoclonal antibody in a double-sandwich ELISA for detection of IgM antibodies to Toxoplasma gondii major surface protein (P30).

Authors:  J Y Cesbron; A Capron; G Ovlaque; F Santoro
Journal:  J Immunol Methods       Date:  1985-10-24       Impact factor: 2.303

8.  Platelia-Toxo IgA, a new kit for early diagnosis of congenital toxoplasmosis by detection of anti-P30 immunoglobulin A antibodies.

Authors:  A Decoster; B Slizewicz; J Simon; C Bazin; F Darcy; G Vittu; C Boulanger; Y Champeau; J L Demory; M Duhamel
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

9.  Immunoblot analysis of Toxoplasma gondii antigens by human immunoglobulins G, M, and A antibodies at different stages of infection.

Authors:  P Partanen; H J Turunen; R T Paasivuo; P O Leinikki
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

10.  IgA antibody response during acquired and congenital toxoplasmosis.

Authors:  M H Bessières; C Roques; A Berrebi; V Barre; M Cazaux; J P Séguéla
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

View more
  2 in total

1.  Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women.

Authors:  P A Jenum; B Stray-Pedersen
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

2.  Diagnosis of toxoplasmosis by joint detection of immunoglobulin A and immunoglobulin M.

Authors:  M Arcavi; G Orfus; G Griemberg
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.